C section News and Research

RSS

Proteins called ankyrins required to prevent muscular dystrophy

A protein that was first identified for playing a key role in regulating normal heart rhythms also appears to be significant in helping muscle cells survive the forces of muscle contraction.

13 Jan 2009

Tiny particle syringe for drug delivery

A tiny particle syringe composed of polymer layers and nanoparticles may provide drug delivery that targets diseased cells without harming the rest of the body, according to a team of chemical engineers.

12 Jan 2009

Epidurals and spinal anesthetics safer than previously reported

The largest ever prospective study [1,2] into the major complications [3] of epidurals and spinal anaesthetics published in the British Journal of Anaesthesia today (Monday 12 January 2009) concludes that previous studies have over-estimated the risks of severe complications of these procedures.

12 Jan 2009

Missing DNA the culprit in epilepsy?

An international team of scientists have identified a genetic risk factor for epilepsy which may lead to a better understanding of what causes the seizures and the development of new treatments for the condition.

12 Jan 2009

Repeat cesarean deliveries before 39 weeks raises risk of neonatal illness

Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.

7 Jan 2009

Discovery of more efficient way to create induced Pluripotent Stem (iPS) cells

A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.

7 Jan 2009

Levitating nanomechanics shows potential to improve medicine

Magicians have long created the illusion of levitating objects in the air. Now researchers at the National Institutes of Health and Harvard University have actually levitated an object, suspending it without the need for external support.

7 Jan 2009

SpectraScience awarded U.S. patent for methods and apparatus for evaluating image focus

SpectraScience, Inc. has announced that it has been awarded U.S. Patent number 7,469,160 for its methods and apparatus for evaluating image focus.

6 Jan 2009

Maternity leave appears to decrease cesarean deliveries and increase breastfeeding

Two new studies led by researchers at the University of California, Berkeley, suggest that taking maternity leave before and after the birth of a baby is a good investment in terms of health benefits for both mothers and newborns.

5 Jan 2009

Adult-onset diabetes slows mental functioning in several ways, with deficits appearing early

Adults with diabetes experience a slowdown in several types of mental processing, which appears early in the disease and persists into old age, according to new research.

5 Jan 2009

Inherited factors play key role in breast cancer

New research in mice and five independent collections of human breast tumors has enabled National Cancer Institute (NCI) scientists to confirm that genes for factors contributing to susceptibility for breast cancer metastasis can be inherited.

5 Jan 2009

Next generation intermittent urinary catheters

Rochester Medical Corporation (NASDAQ:ROCM) today announced the introduction of Magic3(TM), its new line of intermittent urinary catheters.

18 Dec 2008

Policymakers, the media and the public should use 20 specific health indicators

Policymakers, the media, and the public should focus on 20 specific health indicators as "yardsticks" to measure the overall health and well-being of Americans, says a new report from the Institute of Medicine.

17 Dec 2008

ZOLL Medical cleared to market defibrillator with WiFi option

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL R Series Code-Ready clinical defibrillator with a WiFi option that allows wireless communication between the defibrillator and standard hospital networks to help ensure code-readiness and download patient data.

16 Dec 2008

Study of placenta unexpectedly leads to cancer gene

University of Rochester Medical Center scientists discovered a gene mutation that impairs the placenta and also is influential in cancer development, according to a study published online December 16, 2008, in the journal PLoS (Public Library of Science) Biology.

16 Dec 2008

Three-quarters of youths with type 1 diabetes have vitamin D deficiency

Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center - findings that suggest children with the disease may need vitamin D supplementation to prevent bone fragility later in life.

15 Dec 2008

Serious health problems related to late preterm births

More than half a million babies are born preterm in the United States each year, and preterm births are on the rise.

12 Dec 2008

Comparable data on maternal and infant in Europe available for the first time

Promoting healthy pregnancy and safe childbirth is a goal of all European health care systems.

12 Dec 2008

An evidence-based approach to theories of medical decision making and health

As a way to help both the sick and their medical care providers to make the best healthcare decisions possible, a special section of the current November/December 2008 issue of Medical Decision Making examines three current evidenced-based theories that can help to improve assessments, assist in prevention programs, and help with intervention efforts.

12 Dec 2008

$Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma$

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

10 Dec 2008